Avanza Fonder’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$38.9M Buy
33,652
+3,058
+10% +$3.61M 0.75% 22
2026
Q2
$36.7M Buy
30,594
+635
+2% +$649K 0.8% 23
2026
Q1
$27.6M Sell
29,959
-1,515
-5% -$1.54M 0.76% 22
2025
Q4
$33.8M Buy
31,474
+28,881
+1,114% +$27.6M 0.86% 18
2025
Q3
$1.98M Buy
2,593
+212
+9% +$158K 0.05% 255
2025
Q2
$1.86M Sell
2,381
-6
-0.3% -$4.66K 0.06% 258
2025
Q1
$1.95M Sell
2,387
-613
-20% -$510K 0.06% 246
2024
Q4
$2.32M Buy
+3,000
New +$2.48M 0.07% 228

Other funds holding LLY

Avanza Fonder's LLY Position: Q3 2026 in Review

Avanza Fonder increased its Eli Lilly (LLY) stake by 10% in Q3 2026, buying an estimated $3.61M and bringing the position to 33,652 shares worth $38.9M. The position accounts for 0.75% of the portfolio, ranked #22.

Avanza Fonder first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 2,091 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Avanza Fonder held 33,652 shares of Eli Lilly worth $38.9M as of Q3 2026.
  • Avanza Fonder bought 3,058 Eli Lilly shares in Q3 2026, an estimated $3.61M.
  • Eli Lilly made up 0.75% of Avanza Fonder's portfolio in Q3 2026, its #22 holding.
  • Avanza Fonder first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • 2,091 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Avanza Fonder's 13F filing for Q3 2026, filed 13 Oct 2026.